尼美舒利:急性疼痛的安全性和有效性的关键评价。

Q3 Medicine
Mangesh Tiwaskar, Sushant Charde, Nikhil Balankhe, Ashok Hegde, Manish Deodhar, Ajitkumar Gondane, Dattatray Pawar, Akhilesh Sharma
{"title":"尼美舒利:急性疼痛的安全性和有效性的关键评价。","authors":"Mangesh Tiwaskar, Sushant Charde, Nikhil Balankhe, Ashok Hegde, Manish Deodhar, Ajitkumar Gondane, Dattatray Pawar, Akhilesh Sharma","doi":"10.59556/japi.73.0870","DOIUrl":null,"url":null,"abstract":"<p><p>Nimesulide, a potent nonsteroidal anti-inflammatory drug (NSAID), has garnered attention for its distinct mechanism of action, characterized by its selective inhibition of cyclooxygenase-2 (COX-2) and multifaceted pharmacological properties. Extensive clinical evidence supports its safety and efficacy in addressing acute pain syndromes. In this comprehensive review, we undertake a thorough examination of various dimensions surrounding nimesulide, encompassing its historical evolution, intricate mode of action, pharmacokinetic attributes, clinical efficacy in managing acute pain, and notably its safety profile. The historical backdrop of nimesulide's development and evolution is explored, shedding light on the contextual framework of its emergence as a therapeutic agent. A detailed elucidation of its molecular mechanisms elucidates its preferential COX-2 inhibition and its impact on inflammatory pathways, providing insights into its efficacy in pain modulation. Furthermore, a comprehensive analysis of nimesulide's pharmacokinetic properties is provided, highlighting its absorption, distribution, metabolism, and excretion dynamics, which contribute to its clinical efficacy and safety profile. This review meticulously evaluates the clinical evidence supporting nimesulide's effectiveness in alleviating acute pain across various etiologies. Moreover, particular emphasis is placed on scrutinizing its safety profile, drawing comparisons with other NSAIDs. Through a critical synthesis of available data, nimesulide emerges as possessing a favorable safety profile, distinguishing itself from its counterparts in terms of gastrointestinal and cardiovascular tolerability. In conclusion, this review underscores the promising safety and efficacy profile of nimesulide in the management of acute pain, positioning it as a valuable therapeutic option. The positive benefit-to-risk evaluation further reinforces its utility in clinical practice, offering clinicians a well-founded choice for addressing acute pain syndromes effectively.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"73 3","pages":"e22-e28"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nimesulide: Critical Appraisal of Safety and Efficacy in Acute Pain.\",\"authors\":\"Mangesh Tiwaskar, Sushant Charde, Nikhil Balankhe, Ashok Hegde, Manish Deodhar, Ajitkumar Gondane, Dattatray Pawar, Akhilesh Sharma\",\"doi\":\"10.59556/japi.73.0870\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Nimesulide, a potent nonsteroidal anti-inflammatory drug (NSAID), has garnered attention for its distinct mechanism of action, characterized by its selective inhibition of cyclooxygenase-2 (COX-2) and multifaceted pharmacological properties. Extensive clinical evidence supports its safety and efficacy in addressing acute pain syndromes. In this comprehensive review, we undertake a thorough examination of various dimensions surrounding nimesulide, encompassing its historical evolution, intricate mode of action, pharmacokinetic attributes, clinical efficacy in managing acute pain, and notably its safety profile. The historical backdrop of nimesulide's development and evolution is explored, shedding light on the contextual framework of its emergence as a therapeutic agent. A detailed elucidation of its molecular mechanisms elucidates its preferential COX-2 inhibition and its impact on inflammatory pathways, providing insights into its efficacy in pain modulation. Furthermore, a comprehensive analysis of nimesulide's pharmacokinetic properties is provided, highlighting its absorption, distribution, metabolism, and excretion dynamics, which contribute to its clinical efficacy and safety profile. This review meticulously evaluates the clinical evidence supporting nimesulide's effectiveness in alleviating acute pain across various etiologies. Moreover, particular emphasis is placed on scrutinizing its safety profile, drawing comparisons with other NSAIDs. Through a critical synthesis of available data, nimesulide emerges as possessing a favorable safety profile, distinguishing itself from its counterparts in terms of gastrointestinal and cardiovascular tolerability. In conclusion, this review underscores the promising safety and efficacy profile of nimesulide in the management of acute pain, positioning it as a valuable therapeutic option. The positive benefit-to-risk evaluation further reinforces its utility in clinical practice, offering clinicians a well-founded choice for addressing acute pain syndromes effectively.</p>\",\"PeriodicalId\":22693,\"journal\":{\"name\":\"The Journal of the Association of Physicians of India\",\"volume\":\"73 3\",\"pages\":\"e22-e28\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of the Association of Physicians of India\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.59556/japi.73.0870\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of the Association of Physicians of India","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59556/japi.73.0870","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

尼美舒利是一种强效非甾体抗炎药(NSAID),因其独特的作用机制(选择性抑制环氧化酶 2 (COX-2))和多方面的药理特性而备受关注。广泛的临床证据支持其在治疗急性疼痛综合征方面的安全性和有效性。在这篇综述中,我们对尼美舒利的各个方面进行了深入研究,包括其历史演变、复杂的作用模式、药代动力学特性、治疗急性疼痛的临床疗效,尤其是其安全性。书中探讨了尼美舒利发展和演变的历史背景,揭示了其作为一种治疗药物出现的背景框架。对尼美舒利分子机制的详细阐释阐明了其对 COX-2 的优先抑制作用及其对炎症通路的影响,为了解其在疼痛调节方面的功效提供了深入的见解。此外,还对尼美舒利的药代动力学特性进行了全面分析,重点介绍了其吸收、分布、代谢和排泄动态,这些都有助于了解其临床疗效和安全性。本综述细致评估了支持尼美舒利有效缓解各种病因引起的急性疼痛的临床证据。此外,还特别强调了尼美舒利的安全性,并将其与其他非甾体抗炎药进行了比较。通过对现有数据的批判性综合,尼美舒利具有良好的安全性,在胃肠道和心血管耐受性方面有别于同类药物。总之,本综述强调了尼美舒利在治疗急性疼痛方面具有良好的安全性和有效性,使其成为一种有价值的治疗选择。积极的效益风险评估进一步加强了尼美舒利在临床实践中的实用性,为临床医生有效治疗急性疼痛综合征提供了一个有充分依据的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Nimesulide: Critical Appraisal of Safety and Efficacy in Acute Pain.

Nimesulide, a potent nonsteroidal anti-inflammatory drug (NSAID), has garnered attention for its distinct mechanism of action, characterized by its selective inhibition of cyclooxygenase-2 (COX-2) and multifaceted pharmacological properties. Extensive clinical evidence supports its safety and efficacy in addressing acute pain syndromes. In this comprehensive review, we undertake a thorough examination of various dimensions surrounding nimesulide, encompassing its historical evolution, intricate mode of action, pharmacokinetic attributes, clinical efficacy in managing acute pain, and notably its safety profile. The historical backdrop of nimesulide's development and evolution is explored, shedding light on the contextual framework of its emergence as a therapeutic agent. A detailed elucidation of its molecular mechanisms elucidates its preferential COX-2 inhibition and its impact on inflammatory pathways, providing insights into its efficacy in pain modulation. Furthermore, a comprehensive analysis of nimesulide's pharmacokinetic properties is provided, highlighting its absorption, distribution, metabolism, and excretion dynamics, which contribute to its clinical efficacy and safety profile. This review meticulously evaluates the clinical evidence supporting nimesulide's effectiveness in alleviating acute pain across various etiologies. Moreover, particular emphasis is placed on scrutinizing its safety profile, drawing comparisons with other NSAIDs. Through a critical synthesis of available data, nimesulide emerges as possessing a favorable safety profile, distinguishing itself from its counterparts in terms of gastrointestinal and cardiovascular tolerability. In conclusion, this review underscores the promising safety and efficacy profile of nimesulide in the management of acute pain, positioning it as a valuable therapeutic option. The positive benefit-to-risk evaluation further reinforces its utility in clinical practice, offering clinicians a well-founded choice for addressing acute pain syndromes effectively.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
509
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信